Actively Recruiting
Comparing the Safety and Effectiveness of Tafenoquine and Primaquine with Chloroquine for Treating Plasmodium Vivax Malaria in Indian Patients Aged 2 to 64 Years
Led by GlaxoSmithKline · Updated on 2026-10-01
324
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect data on the effectiveness and safety of two medications, tafenoquine and primaquine, when each is taken alongside chloroquine for treating Plasmodium vivax malaria. The study focuses on Indian participants aged 2 to under 65 years, supporting tafenoquines registration in India. It is a randomized, open-label, multi-center, phase 3 trial comparing these treatments for relapse prevention. Participants are assigned to one of two groups. One group receives a single oral dose of tafenoquine on Day 1 or 2 plus daily chloroquine on Days 1 to 3. The other group receives daily oral primaquine from Day 1 or 2 through Day 14 or 15, alongside daily chloroquine on Days 1 to 3. This treatment period is followed by monitoring to assess relapse prevention. During the study, participants undergo evaluations including blood smears to detect malaria recurrence, blood tests to monitor hemolysis and liver function, and safety assessments for adverse events. These are conducted at multiple intervals up to six months post-treatment. The main outcome is the number of participants who remain free from malaria recurrence six months after treatment. Safety and laboratory parameters are closely monitored throughout the study.
CONDITIONS
Brief Title
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
Research Team
U
US GSK Clinical Trials Call Center
E
EU GSK Clinical Trials Call Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here